Results 191 to 200 of about 2,272 (238)

1-Deamino-8-D-arginine vasopressin as a therapy for the bleeding diathesis of renal failure.

American journal of nephrology, 1984
The treatment of the bleeding diathesis of renal failure remains unsatisfactory. 1-Deamino-8-D-arginine vasopressin (DDAVP) has recently been shown to shorten the prolonged bleeding time of renal failure and may as a result diminish the risk of clinical hemorrhage. We describe 2 cases where DDAVP was used successfully in the management of hemorrhage in
A J, Watson, J A, Keogh
openaire   +1 more source

[Tritium-labeled reactive analogs of [1,6-alpha-aminosuberic acid, 8-arginine] vasopressin (deamino-dicarba-[8-arginine] vasopressin. synthesis and properties].

Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1983
The synthesis of three reactive analogues of [1,6-alpha-aminosuberic acid, 8-arginine]-vasopressin ([Asu1,6,Arg8]vasopressin) is described. Two peptide hormone analogues contain in the p-position of Phe2 the azido or 3-(3-methyl-3-diazirinyl)propanoylamino residue, which can be converted by photoactivation into nitrenes and carbenes, respectively.
F, Fahrenholz, H S, Husseini, J L, Morgat, K H, Thierauch   +3 more
openaire   +1 more source

1-Deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease.

American journal of hematology, 1985
The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent.
W T, Hanna, J, Slywka, J, Dent, Z M, Ruggeri, T S, Zimmerman   +4 more
openaire   +1 more source

Response to 1-deamino-8-D-arginine vasopressin in von Willebrand disease.

Haemostasis, 1995
The synthetic agent, 1-deamino-8-D-arginine vasopressin (DDAVP), is generally regarded to be the treatment of choice for persons with type I von Willebrand disease (vWD), and may be useful in type IIA vWD as well. Several formulations of the drug are available, including a highly concentrated intranasal spray formulation which is ideal for home use ...
openaire   +1 more source

Normal acid-base equilibrium in acute hyponatremia and mixed alkalosis in chronic hyponatremia induced by arginine vasopressin or 1-deamino-8-D-arginine vasopressin in rats.

The Journal of laboratory and clinical medicine, 1994
info:eu-repo/semantics ...
Decaux, Guy, Crenier, Laurent, Namias, Bernard, Gervy Decoster, Christine, Soupart, Alain   +4 more
openaire   +2 more sources

Solid-phase synthesis and some pharmacological properties of deamino-4-threonine analogs of the vasopressins and vasotocin and [deamino]arginine-vasotocin

Journal of Medicinal Chemistry, 1973
M, Manning, E J, Coy, M, Acosta, W H, Sawyer   +3 more
openaire   +2 more sources

Preparation of antibodies to [8-D-arginine]deamino-vasopressin and study of their cross-reactivity with vasopressin analogues

Collection of Czechoslovak Chemical Communications, 1978
Jiřina Slaninová, Tomislav Barth, Jana Škopková, Ivo Bláha, František Franěk   +4 more
openaire   +1 more source

Use of deamino-8-d arginine vasopressin in a patient with moderate von Willebrand's disease

Journal of Oral and Maxillofacial Surgery, 1987
A O, Abubaker, F A, Bontempo, T W, Braun
openaire   +2 more sources

Inhibition of the Antidiuretic Effect of 1-Deamino-8D-Arginine Vasopressin (DDAVP) by Glibenclamide

Hormone and Metabolic Research, 1975
J. Radó, L. Borbély
openaire   +1 more source

Shortening of Bleeding Time by 1-Deamino-8-Arginine Vasopressin (DDAVP) in the Absence of Platelet von Willebrand Factor in Gray Platelet Syndrome

, 1987
Sharron L. Pfueller, Margaret A. Howard, James G. White, Chandrasekhara Menon, E.W. Berry   +4 more
openalex   +1 more source